ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Asterias Biotherapeutics Common Series A

Asterias Biotherapeutics Common Series A (AST)

0.945
0.00
(0.00%)
At close: 18 January 8:00AM
0.945
0.00
( 0.00% )

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.945
Bid
-
Offer
-
Volume
0.00
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.945
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

AST Latest News

Asterias Provides Top Line 12 Month Data Update for its OPC1 Phase 1/2a Clinical Trial in Severe Spinal Cord Injury

FREMONT, Calif., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

BioTime Announces Management Changes Concurrent With Participation at 2019 J.P. Morgan Healthcare Conference and 2019 Biotech...

ALAMEDA, Calif., Jan. 04, 2019 (GLOBE NEWSWIRE) -- BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced the appointment...

Asterias Biotherapeutics Announces Fourth Patient Dosed in First-in-Human Clinical Study of Immunotherapy VAC2 in Non-Small C...

FREMONT, Calif., Nov. 27, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cellular immunotherapies to treat cancer...

Asterias Biotherapeutics Reports Third Quarter Results

Clinical Programs Continue to ProgressRecent Transactions with affiliate of Novo Nordisk Increased Cash-on-Hand and Reduced Annual Operating ExpensesRecently Announced Definitive Merger Agreement...

BioTime and Asterias Biotherapeutics Enter Into Definitive Merger Agreement to Create Leading Cell Therapy Company

BioTime Acquires Two Clinical-Stage Cell Therapy Product Candidates Addressing Significant Unmet Needs in Spinal Cord Injury and Immuno-Oncology Asterias Stockholders to Receive 0.71...

BioTime Reports Third Quarter 2018 Financial Results and Provides Business Update

Industry Veteran Brian M. Culley Appointed as CEO Signed Agreement to Acquire Asterias Biotherapeutics, Inc. Received $43.2 Million from AgeX Sale Transaction with Juvenescence...

Asterias Biotherapeutics to Report Third Quarter 2018 Results on November 12, 2018

FREMONT, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

Asterias Biotherapeutics Announces Positive Outcome from Data Review from OPC1 Spinal Cord Injury Study

Meeting with Food and Drug Administration Remains on Track for End of 2018 FREMONT, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a...

Asterias Biotherapeutics Announces Facilities and IP License Option Agreements

FREMONT, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

FDA Accepts Asterias Biotherapeutics’ Request to Meet and Discuss Next Phase of Development for OPC1 Spinal Cord Injury Cli...

FREMONT, Calif., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

AST - Frequently Asked Questions (FAQ)

What is the current Asterias Biotherapeutics, Inc. share price?
The current share price of Asterias Biotherapeutics, Inc. is US$ 0.945
What is the 1 year trading range for Asterias Biotherapeutics, Inc. share price?
Asterias Biotherapeutics, Inc. has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ROLRHigh Roller Technologies Inc
US$ 6.50
(10.41%)
215
ITPIT Tech Packaging Inc
US$ 0.47
(9.28%)
203.42k
XTNTXtant Medical Holdings Inc
US$ 0.5513
(6.02%)
102
JOBGEE Group Inc
US$ 0.2789
(5.64%)
3.48k
CANFCan Fite BioPharma Ltd
US$ 1.62
(4.52%)
142
AEONAEON Biopharma Inc
US$ 0.1425
(-7.47%)
601.68k
DDCDDC Enterprise Limited
US$ 0.1827
(-6.02%)
31.89k
HCWCHealthy Choice Wellness Corp
US$ 1.1574
(-5.90%)
1.26k
AMBOAmbow Education Holding Ltd
US$ 1.71
(-5.52%)
2.6k
GNSGenius Group Limited
US$ 0.638
(-5.48%)
54.63k
SPYSPDR S&P 500
US$ 597.299
(-0.05%)
5.66M
HYGiShares iBoxx Dollar High Yield Corporate Bond
US$ 79.48
(0.03%)
5.26M
IEFAiShares Core MSCI EAFE ETF
US$ 71.50
(0.20%)
3.47M
GDXVanEck Gold Miners ETF
US$ 36.84
(0.24%)
3.2M
INDAiShares MSCI India ETF
US$ 51.2093
(0.06%)
2.28M

Discussion

View Full Feed
tw0122 tw0122 5 minutes ago
Some hits on this China EV low floater $2.14 + 20% 

CJET
investisseur101 investisseur101 5 minutes ago
on another website and on the SmX board today there were 4-5 big traders (with 5k-10000 followers) in PM showing charts assuming news for SMX for next week..hoping for us also.
SMX
cojoboy cojoboy 6 minutes ago
Everyone thought Telsa was a POS @$1...In no way comparing this or any stock to Telsa..but..now over $2k....????🤔🤔🤔
RDAR
ChannelTrader ChannelTrader 6 minutes ago
They hate Trump.
EXCLUSIVE: Local Police Departments Are Refusing To Help DC Secure Trump’s Inauguration

https://www.msn.com/en-us/news/us/exclusive-local-police-departments-are-refusing-to-help-dc-secure-trump-s-inauguration/ar-AA1xorkm?ocid=msedgntp&pc=HCTS&cvid=f53683ea00574
getmoreshares getmoreshares 6 minutes ago
😎😎😎😎😎READY?😎😎😎😎😎
CGAC
100lbStriper 100lbStriper 7 minutes ago
kind of like shadow people just gotta hope they like you.
marcis marcis 8 minutes ago
You claim chart knowledge

The small volume today is factual, showing very bullish

I don’t need you to agree but I’m pointing out how wrong you are posting
RDAR
KILLAZILLA KILLAZILLA 9 minutes ago
NOT ONE "ADVISOR" DID ANYTHING FOR xeri. ONLY thing was xeri trying to DUMP shares to NAIVE RETAIL after said pr....FACT!!!!

I DON'T EXPECT ANYTHING DIDN'T THIS TIME EITHER...
XERI
Spicoli Spicoli 9 minutes ago
You all are a special kimda stupid if you think that any of our posts here or on twitter move the needle. Come back to realville. 
FNMA
jsc52033 jsc52033 9 minutes ago
Aren't we to get a spin off of shares from the sale of they did a while back
BMXI
northam43 northam43 10 minutes ago
Report #1 Status Report.

https://investorshub.advfn.com/uimage/uploads/2025/1/17/gjchi1_Status_Report.PNG
MRJ25 MRJ25 10 minutes ago
Pulte can be the interim director and later on confirmed.
FNMA
trade15 trade15 10 minutes ago
noradio
That seems to be a very rare book. Your very lucky to have one. I bought a large lot of Canadian Mines Handbooks dating back to the 1930's from an estate sale recently hoping it would be one of the extra books included.
Trade15
fwb fwb 11 minutes ago
And will SOUNDHOUND provide the VOICE RECOGNITION AI?
NVDA
HoldHigh HoldHigh 11 minutes ago
New dispensary approved for TCNNF in palm harbor fl. Look for it to open soon.
TCNNF
HoldEm777 HoldEm777 12 minutes ago
If you say so then it has to be true. 😉
RDAR
weedtrader420 weedtrader420 12 minutes ago
Government starting new virus MRNA When you can’t beat them, you join them🤑🤑🤑🤑
MRNA
gitreal gitreal 12 minutes ago
Your "geologist friend" thinks a mining prospect with hardly any gold, and only 100,000 tons of rock averaging about 3 oz/ton silver is......spectacular!? Are you sure you heard him right? I think he probably said "craptacular", not spectacular.
AABB
Craig305 Craig305 12 minutes ago
News pending? LOL... 🤣🤣🤣

"F", DO BETTER!

The market maker signals is fake news!

How many times have you posted this same statement and how many times has news been released immediately afterwards?  🤣🤣
BIEL
janice shell janice shell 13 minutes ago
Wikipedia is much better now than it once was. For heaven's sake. Read the footnotes. Click on them. Read the sources.
zxjoshuaxz zxjoshuaxz 13 minutes ago
Not fake for me! Sitting at 26,305 shares right now and I started accumulating in December 2022. My mom has unfortunately been in this for about 15 years. Yet she's still hopeful and was shocked when it hit $7! I wish I could accumulate more but the days of 50 cents for months are gone
FNMA
barnyarddog barnyarddog 13 minutes ago
Member of Nobel Family Invests in US Wealth Firm
A consortium led by Peter Nobel investing as much as $25 million in Cardea, which is rebranding to Fourcore Capital.

Ben Stupples | Aug 22, 2024
https://www.wealthmanagement.com/industry/member-nobel-family-invests-us-weal
GBBK
loanshark007 loanshark007 13 minutes ago
Hey chief, it's 2025 not 2023. Why don't you tell potential investors about the upcoming reverse split and how it will decimate them. You have zero credibility and continue to look like a fool.
GRST

Your Recent History

Delayed Upgrade Clock